2004
DOI: 10.1073/pnas.0404956101
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling

Abstract: Prostate cancer is the most common solid tumor in men, and it shares with all cancers the hallmark of elevated, nonhomeostatic cell proliferation. Here we have tested the hypothesis that the SONIC HEDGEHOG (SHH)-GLI signaling pathway is implicated in prostate cancer. We report expression of SHH-GLI pathway components in adult human prostate cancer, often with enhanced levels in tumors versus normal prostatic epithelia. Blocking the pathway with cyclopamine or anti-SHH antibodies inhibits the proliferation of G… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

36
498
5
2

Year Published

2007
2007
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 468 publications
(541 citation statements)
references
References 55 publications
(45 reference statements)
36
498
5
2
Order By: Relevance
“…Given the relevant role of Fbxl17 in regulating Hh signaling and that Hh signaling activity has been implicated in the proliferation of prostate cancer cell lines (Karhadkar et al , 2004; Sanchez et al , 2004), we further tested the effect of Fbxl17 on Hh activation by quantifying Gli1 mRNA levels upon either depletion or expression of Fbxl17 using PC3 cells. Fbxl17 silencing resulted in a decrease in Gli1 mRNA levels (Appendix Fig S2A), and contrarily, Fbxl17 expression led to an increase in Gli1 mRNA levels (Appendix Fig S2B).…”
Section: Resultsmentioning
confidence: 99%
“…Given the relevant role of Fbxl17 in regulating Hh signaling and that Hh signaling activity has been implicated in the proliferation of prostate cancer cell lines (Karhadkar et al , 2004; Sanchez et al , 2004), we further tested the effect of Fbxl17 on Hh activation by quantifying Gli1 mRNA levels upon either depletion or expression of Fbxl17 using PC3 cells. Fbxl17 silencing resulted in a decrease in Gli1 mRNA levels (Appendix Fig S2A), and contrarily, Fbxl17 expression led to an increase in Gli1 mRNA levels (Appendix Fig S2B).…”
Section: Resultsmentioning
confidence: 99%
“…Deregulation of HH signaling causes malformation and tumor formation, with the first example being basal cell carcinomas (BCC) (Johnson et al, 1996;Hahn et al, 1996b). In a number of tumors that were recently found to include prostatic and pancreatic cancers, HH signaling is abnormally upregulated, and effective signaling inhibition can repress tumor growth and induce apoptosis (Sanchez et al, 2004). Among core components of the HH pathway, the secreted ligand HH, the membrane receptor Patched (PTCH), the membrane signal transductor Smoothened (SMO) and the transcription factor Ci/glioma (GLI) are evolutionarily conserved from insects to mammals.…”
Section: Introductionmentioning
confidence: 99%
“…This concept received substantial impetus from two early reports of cyclopamine- or Shh antibody-mediated suppression of prostate cancer cell growth in vitro and in vivo [66,96], and the outcomes of these experimental studies were viewed as evidence for an active auto-crine-like hedgehog signaling process in these cell lines. This conclusion should now be reconsidered, especially in light of the concerns discussed previously.…”
Section: Overview Of Hedgehog/gli In Prostate Cancermentioning
confidence: 99%
“…There are general concerns that the so-called ‘normal’ regions of human prostate specimens that are available for study might be affected by the common prostate benign disease states that might also invoke abnormal hedgehog responses [100] and this raises questions regarding the establishment of normal prostate basal expression levels for any of these genes. Approaches that assess RNA levels by in situ hybridization are complicated by the uneven cellular architecture of a prostate tumor (in which the cellularity of the stroma can appear sparse compared with the adjacent epithelium) and this might account for the conflicting findings of Gli1 RNAs localized to benign and malignant prostate epithelium in one study [96] versus selective expression in the stroma around tumors in another [100]. Likewise, quantitative reverse-transcriptase PCR approaches that involve bulk extraction from tumor tissues are complicated by the comixtures of tumor and benign stromal cells in the specimens that complicate analysis, so it is difficult to comment on observations based on this approach.…”
Section: Overview Of Hedgehog/gli In Prostate Cancermentioning
confidence: 99%